Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production

被引:239
作者
Pae, HO
Oh, GS
Choi, BM
Chae, SC
Kim, YM
Chung, KR
Chung, HT
机构
[1] Wonkwang Univ, Sch Med, Dept Microbiol & Immunol, Iksan 570749, Chonbuk, South Korea
[2] Wonkwang Univ, Genom Res Ctr Immune Disorders, Iksan 570749, Chonbuk, South Korea
[3] Kangwon Natl Univ, Sch Med, Vasc Syst Res Ctr, Chunchon, Kangwon Do, South Korea
[4] Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Chunchon, Kangwon Do, South Korea
[5] Seoul Natl Univ, Sch Med, Seoul, South Korea
关键词
D O I
10.4049/jimmunol.172.8.4744
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Heme oxygenase-1 (HO-1) catabolizes heme into CO, biliverdin, and free iron and serves as a protective enzyme by virtue of its anti-inflammatory, antiapoptotic, and antiproliferative actions. Previously, we have demonstrated that human CD4(+) T cells express HO-1 and that HO-1-overexpressing Jurkat T cells tend to display lower proliferative response. The aim of this study is to elucidate the mechanism(s) by which HO-1 can mediate its antiproliferative effect on CD4(+) T cells. Among the three HO-1 byproducts, only CO showed suppressive effect on T cell proliferation in response to anti-CD3 plus anti-CD28 Abs, mimicking the antiproliferative action of HO-1. CO blocked the cell cycle entry of T cells, which was independent of the guanylate cyclase/cGMP pathway. CO also suppressed the secretion of IL-2, and this suppressive effect of CO on IL-2 secretion mediated the antiproliferative action of CO. CO selectively inhibited the extracellular signal-regulated kinase pathway, which could explain the suppressive effects of CO on T cell proliferation and IL-2 secretion. Based on these findings, we suggest that HO-1/CO suppresses T cell proliferation and IL-2 secretion, possibly via its inhibition of extracellular signal-regulated kinase activation.
引用
收藏
页码:4744 / 4751
页数:8
相关论文
共 32 条
[1]   The Ras/MAPK cascade and the control of positive selection [J].
Alberola-Ila, J ;
Hernández-Hoyos, G .
IMMUNOLOGICAL REVIEWS, 2003, 191 (01) :79-96
[2]   THE ROLE OF JUN, FOS AND THE AP-1 COMPLEX IN CELL-PROLIFERATION AND TRANSFORMATION [J].
ANGEL, P ;
KARIN, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1072 (2-3) :129-157
[3]   Systemic rather than local heme oxygenase-1 overexpression improves cardiac allograft outcomes in a new transgenic mouse [J].
Araujo, JA ;
Meng, LZ ;
Tward, AD ;
Hancock, WW ;
Zhai, Y ;
Lee, A ;
Ishikawa, K ;
Iyer, S ;
Buelow, R ;
Busuttil, RW ;
Shih, DM ;
Lusis, AJ ;
Kupiec-Weglinski, JW .
JOURNAL OF IMMUNOLOGY, 2003, 171 (03) :1572-1580
[4]   Maintenance of human T cell anergy: Blocking of IL-2 gene transcription by activated Rap1 [J].
Boussiotis, VA ;
Freeman, GJ ;
Berezovskaya, A ;
Barber, DL ;
Nadler, LM .
SCIENCE, 1997, 278 (5335) :124-128
[5]   Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention [J].
Chang, F ;
Steelman, LS ;
Lee, JT ;
Shelton, JG ;
Navolanic, PM ;
Blalock, WL ;
Franklin, RA ;
McCubrey, JA .
LEUKEMIA, 2003, 17 (07) :1263-1293
[6]  
Chen D, 1999, J IMMUNOL, V163, P5796
[7]   Nitric oxide-mediated cytoprotection of hepatocytes from glucose deprivation-induced cytotoxicity: Involvement of heme oxygenase-1 [J].
Choi, BM ;
Pae, HO ;
Kim, YM ;
Chung, HT .
HEPATOLOGY, 2003, 37 (04) :810-823
[8]   Measurement of MAP kinase activation by flow cytometry using phospho-specific antibodies to MEK and ERK: Potential for pharmacodynamic monitoring of signal transduction inhibitors [J].
Chow, S ;
Patel, H ;
Hedley, DW .
CYTOMETRY, 2001, 46 (02) :72-78
[9]  
DeSilva DR, 1998, J IMMUNOL, V160, P4175
[10]   MAP kinases in the immune response [J].
Dong, C ;
Davis, RJ ;
Flavell, RA .
ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :55-72